Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Suspension of Trading on AIM

9 Oct 2017 07:00

RNS Number : 0024T
Accrol Group Holdings PLC
09 October 2017
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Accrol Group Holdings plc

Update on Suspension of Trading on AIM 

Further to the announcement made by Accrol Group Holdings plc (the "Company" or "Accrol"), on 5 October 2017 at 7.00am titled "Trading Update and Temporary Suspension of Trading on AIM", the Company provides the following update. The Directors believe that the current challenges facing the Company relate largely to FY18 and are likely to have less of an impact on the Company's trading performance in FY19. The Board are therefore confident that, whilst there can be no guarantee, a solution will be found to the Company's short term funding requirements. The Directors continue to review the position and, as part of this review, the Company is engaging with its major shareholders and its bank.Continuing Suspension of Trading on AIMAs a result of the above circumstances trading in the Company's ordinary shares on AIM remains suspended pending clarification of its financial position. 

For further information please contact: 

 

Zeus Capital Limited (Nominated Adviser & Joint Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 20 3829 5000

Liberum Capital Limited (Joint Broker)

 

Clayton Bush / Chris Clarke/ Lucy Sharma / Dominik Götzenberger

Tel: +44 (0) 20 3100 2222

Camarco (Media enquiries) 

 

Jennifer Renwick / Kimberley Taylor

Tel: +44 (0) 203 757 4994

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBBDGSBGBGRI
Date   Source Headline
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.